US › Healthcare

Stereotaxis Inc (STXS)

US · Healthcare · Medical Instruments & Supplies

$1.42+6.77%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$6.3M

Revenue YoY

-15.8%

Net profit

$-5.9M

Profit YoY

-0.7%

EPS

$-0.06

EPS estimate

$-0.06

Net margin

-93.2%

EPS came in at -0.06 against a street estimate of -0.06 — a miss of 10.1%.

Key statistics

Market cap

$132.5M

Forward P/E

19.6

P/B

8.74

Book value

$0.15

EPS (TTM)

$-0.24

52-week high

$3.59

52-week low

$1.24

50-day MA

$1.72

200-day MA

$2.13

Beta

1.40

Analyst view

Analysts rate Stereotaxis Inc a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $4.12.

Shareholding

Insiders

15.29%

Institutions

43.79%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Stereotaxis Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.